Developer docs
API playgroundTry for free, no card

Search company profiles

Medsteer

Full company profile

uuid002neem

Namestring
Medsteer
Legal namestring
Medsteer SAS
Websiteurl
medsteer.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Medsteer SAS is a private French medical technology company specializing in closed-loop anesthesia drug delivery systems. The company's flagship product, EasyTIVA, is a patented platform that automates the dosing of Propofol and Remifentanil during surgical procedures by using real-time EEG-based depth-of-anesthesia indices (BIS and spectral M-Entropy) as feedback to a proprietary control algorithm. EasyTIVA supports both induction and regulation phases and is designed for use across all patient types and all surgical procedures, validated across 25+ multicenter clinical trials and more than 15,000 patient inclusions since 2006 in 9 countries.

Medsteer operates with a small team (11-50 employees) under a dual-channel go-to-market model: direct sales to hospitals and surgical centers for EasyTIVA platform deployment, and technology licensing/integration partnerships with pharmaceutical and medical device companies seeking to embed EEG-guided closed-loop control into their own platforms. The company's technology integrates with third-party brain monitoring systems from Medtronic and GE Healthcare and uses standard syringe pumps within a closed-loop architecture. Pricing is not publicly disclosed and is likely quotation-based for institutional procurement.

In January 2026, Medsteer entered a strategic exclusive collaboration with Cyclerion Therapeutics to integrate its EEG-guided closed-loop control technology into Cyclerion's closed-loop anesthetic platform for CYC-126, an investigational therapy for treatment-resistant depression — a notable expansion of the core technology into psychiatric indications beyond surgical anesthesia. The company is also developing a reference design device as a next-generation tool for anesthesiologists, signaling a transition from a pure technology licensor toward a hardware-enabled medical device company.

Short descriptiontext

Medsteer SAS develops EasyTIVA, a patented closed-loop Total Intravenous Anesthesia platform that automates Propofol and Remifentanil dosing via real-time EEG-guided algorithms, serving hospitals, surgical centers, and anesthesiologists worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSuresnes, France
HQ citystring
Suresnes
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
closed-loop anesthesia, TIVA drug delivery, EEG-guided anesthesia, anesthesia automation systems, depth of anesthesia monitoring
Industry2 codes
PRIMARYHLAHADAJ
Anesthesia & Airway Management Equipment (Workstations, Laryngoscopy, Ventilation adjuncts)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Closed-Loop Anesthesia Delivery Systems
Social media profiles2 records
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1EasyTIVA
Description

Patented technology platform delivering full automation in the dosage of Propofol and Remifentanil for closed-loop total intravenous anesthesia, with real-time EEG-guided drug delivery.

medsteer.com
Core offering1 text field

Medsteer sells the patented EasyTIVA technology platform, a closed-loop Total Intravenous Anesthesia (TIVA) system that fully automates the induction and regulation of Propofol and Remifentanil dosing during surgery. The platform uses a proprietary EEG-guided algorithm that ingests real-time depth-of-anesthesia index values (0–100) from compatible brain monitors and non-invasive forehead sensors, then drives standard syringe pumps in a closed-loop architecture to deliver precise drug amounts. The technology is targeted at hospitals, surgical centers, and anesthesiologists, and is also being licensed for integration into pharmaceutical platforms (e.g., Cyclerion's CYC-126).

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Medsteer is a technology provider in closed-loop anesthesia drug delivery systems. The company's primary product is EasyTIVA, a patented technology platform that automates Propofol and Remifentanil dosing guided by real-time EEG monitoring. EasyTIVA represents the core platform, while the company is also developing a reference design device as a next-generation tool for anesthesiologists. The technology has been validated through over 25 clinical trials with more than 15,000 patient inclusions since 2006.

Product and service1 record
1EasyTIVA
CategoryClosed-Loop Anesthesia Delivery Systems
Description

Patented closed-loop Total Intravenous Anesthesia (TIVA) technology platform that provides full automation in the dosage of Propofol and Remifentanil during surgery. The platform uses a proprietary EEG-guided algorithm that ingests real-time depth-of-anesthesia index values (0–100 scale) from compatible brain monitors and non-invasive disposable forehead sensors, then drives standard syringe pumps in a closed-loop architecture to deliver precise drug amounts during both induction and regulation phases. Validated for all patients and all surgery types and supported by compatibility with Medtronic and GE Healthcare brain monitor systems.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-01-05
Description

Strategic exclusive collaboration to integrate Medsteer's EEG-guided closed-loop control technology into Cyclerion's closed-loop anesthetic platform for CYC-126, an investigational anesthetic-based therapy for treatment-resistant depression. Medsteer provides computational modules, control software, and datasets developed across 25 clinical settings and 9,000 patients. This partnership represents a significant expansion of Medsteer's technology into psychiatric applications beyond surgical anesthesia.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

GE Healthcare is a main supplier of brain monitoring systems compatible with EasyTIVA and offers comprehensive anesthesia delivery and patient monitoring solutions, making it both a partner and a broad incumbent in the same OR ecosystem.

TypeDirect peer
Description

Masimo's SedLine EEG-based depth-of-anesthesia monitor competes directly with the Medtronic/GE monitors that EasyTIVA relies on, and Masimo increasingly integrates analytics into its own OR platform, making it the closest adjacent competitor in EEG-guided anesthesia.

TypeBroad incumbent
Description

Medtronic supplies the BIS brain monitoring system used as input to EasyTIVA, but also markets broader perioperative and patient monitoring portfolios, positioning it as both a partner and a potential full-stack competitor in closed-loop OR automation.

TypeEmerging player
Description

Mindray provides patient monitoring and anesthesia delivery systems including EEG-based depth-of-anesthesia modules, and is rapidly expanding in emerging markets, representing a growing lower-cost competitor to EasyTIVA's positioning.

5Drägerwerk
TypeBroad incumbent
Description

Dräger is a leading global supplier of anesthesia workstations, integrated patient monitoring, and OR IT, and could bundle competing closed-loop capabilities into its Perseus and similar anesthesia platforms over time.

TypeDirect peer
Description

ICU Medical (Smiths Medical infusion portfolio) supplies syringe pumps and infusion systems that are central to closed-loop drug delivery architectures like EasyTIVA, and is a direct adjacency in the closed-loop anesthesia technology stack.

TypeBroad incumbent
Description

Edwards provides hemodynamic monitoring used alongside anesthesia delivery in the OR and has explored closed-loop fluid and drug administration concepts, making it an adjacent incumbent with overlapping clinical use cases.

TypeBroad incumbent
Description

Philips provides perioperative patient monitoring and integrated OR solutions overlapping with Medsteer's clinical environment, and has been investing in decision-support and AI-driven anesthesia analytics that could converge with closed-loop dosing.

9Sedana Medical
TypeEmerging player
Description

Sedana Medical focuses on inhaled sedation in the ICU setting, an adjacent clinical use case to Medsteer's closed-loop IV anesthesia and sedation platform, with overlapping anesthesiology and critical care customer segments.

TypeBroad incumbent
Description

BD offers infusion and medication management technologies used in surgical and ICU sedation settings, and competes in adjacent closed-loop and smart-pump categories relevant to Medsteer's dosing automation value proposition.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medsteer

Closed-Loop Anesthesia Delivery Systemsmedsteer.com

Medsteer SAS develops EasyTIVA, a patented closed-loop Total Intravenous Anesthesia platform that automates Propofol and Remifentanil dosing via real-time EEG-guided algorithms, serving hospitals, surgical centers, and anesthesiologists worldwide.

What Medsteer does

Medsteer SAS is a private French medical technology company specializing in closed-loop anesthesia drug delivery systems. The company's flagship product, EasyTIVA, is a patented platform that automates the dosing of Propofol and Remifentanil during surgical procedures by using real-time EEG-based depth-of-anesthesia indices (BIS and spectral M-Entropy) as feedback to a proprietary control algorithm. EasyTIVA supports both induction and regulation phases and is designed for use across all patient types and all surgical procedures, validated across 25+ multicenter clinical trials and more than 15,000 patient inclusions since 2006 in 9 countries.

Medsteer operates with a small team (11-50 employees) under a dual-channel go-to-market model: direct sales to hospitals and surgical centers for EasyTIVA platform deployment, and technology licensing/integration partnerships with pharmaceutical and medical device companies seeking to embed EEG-guided closed-loop control into their own platforms. The company's technology integrates with third-party brain monitoring systems from Medtronic and GE Healthcare and uses standard syringe pumps within a closed-loop architecture. Pricing is not publicly disclosed and is likely quotation-based for institutional procurement.

In January 2026, Medsteer entered a strategic exclusive collaboration with Cyclerion Therapeutics to integrate its EEG-guided closed-loop control technology into Cyclerion's closed-loop anesthetic platform for CYC-126, an investigational therapy for treatment-resistant depression — a notable expansion of the core technology into psychiatric indications beyond surgical anesthesia. The company is also developing a reference design device as a next-generation tool for anesthesiologists, signaling a transition from a pure technology licensor toward a hardware-enabled medical device company.

Medsteer firmographics

Firmographics
Name
Medsteer
Legal name
Medsteer SAS
Website
https://medsteer.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
1–10 employees
Short description
Medsteer SAS develops EasyTIVA, a patented closed-loop Total Intravenous Anesthesia platform that automates Propofol and Remifentanil dosing via real-time EEG-guided algorithms, serving hospitals, surgical centers, and anesthesiologists worldwide.
Ownership category
akta.pro rank

Medsteer industry classification

Industry
Product category
Closed-Loop Anesthesia Delivery Systems
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHADAJ
Anesthesia & Airway Management Equipment (Workstations, Laryngoscopy, Ventilation adjuncts)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • Closed-loop anesthesia
  • TIVA drug delivery
  • EEG-guided anesthesia
  • Anesthesia automation systems
  • Depth of anesthesia monitoring

Where Medsteer is headquartered

Location

Headquarters

HQ city
Suresnes
HQ country
France
HQ region
Europe

Offices2 records

Markets served

Medsteer business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Distribution channels2 records

Marketing channels2 records

Medsteer product offering

Product offering

Core offering

Medsteer sells the patented EasyTIVA technology platform, a closed-loop Total Intravenous Anesthesia (TIVA) system that fully automates the induction and regulation of Propofol and Remifentanil dosing during surgery. The platform uses a proprietary EEG-guided algorithm that ingests real-time depth-of-anesthesia index values (0–100) from compatible brain monitors and non-invasive forehead sensors, then drives standard syringe pumps in a closed-loop architecture to deliver precise drug amounts. The technology is targeted at hospitals, surgical centers, and anesthesiologists, and is also being licensed for integration into pharmaceutical platforms (e.g., Cyclerion's CYC-126).

Product overview

Medsteer is a technology provider in closed-loop anesthesia drug delivery systems. The company's primary product is EasyTIVA, a patented technology platform that automates Propofol and Remifentanil dosing guided by real-time EEG monitoring. EasyTIVA represents the core platform, while the company is also developing a reference design device as a next-generation tool for anesthesiologists. The technology has been validated through over 25 clinical trials with more than 15,000 patient inclusions since 2006.

Differentiator

Problem solved

Functional benefit

Brands

  • EasyTIVA: Patented technology platform delivering full automation in the dosage of Propofol and Remifentanil for closed-loop total intravenous anesthesia, with real-time EEG-guided drug delivery.

Products and services

  • EasyTIVA Patented closed-loop Total Intravenous Anesthesia (TIVA) technology platform that provides full automation in the dosage of Propofol and Remifentanil during surgery. The platform uses a proprietary EEG-guided algorithm that ingests real-time depth-of-anesthesia index values (0–100 scale) from compatible brain monitors and non-invasive disposable forehead sensors, then drives standard syringe pumps in a closed-loop architecture to deliver precise drug amounts during both induction and regulation phases. Validated for all patients and all surgery types and supported by compatibility with Medtronic and GE Healthcare brain monitor systems.

Companies that use Medsteer

Customer profile

Segments2 records

Ideal customer profiles1 record

Medsteer technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability3 records

Feature4 records

Medsteer partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Cyclerion TherapeuticscoreTechnology or Integration · 5 January 2026Strategic exclusive collaboration to integrate Medsteer's EEG-guided closed-loop control technology into Cyclerion's closed-loop anesthetic platform for CYC-126, an investigational anesthetic-based therapy for treatment-resistant depression. Medsteer provides computational modules, control software, and datasets developed across 25 clinical settings and 9,000 patients. This partnership represents a significant expansion of Medsteer's technology into psychiatric applications beyond surgical anesthesia.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Medsteer competitors and assessment

Company assessment

Broad incumbents

  • GE HealthCare: GE Healthcare is a main supplier of brain monitoring systems compatible with EasyTIVA and offers comprehensive anesthesia delivery and patient monitoring solutions, making it both a partner and a broad incumbent in the same OR ecosystem.
  • Medtronic: Medtronic supplies the BIS brain monitoring system used as input to EasyTIVA, but also markets broader perioperative and patient monitoring portfolios, positioning it as both a partner and a potential full-stack competitor in closed-loop OR automation.
  • Drägerwerk: Dräger is a leading global supplier of anesthesia workstations, integrated patient monitoring, and OR IT, and could bundle competing closed-loop capabilities into its Perseus and similar anesthesia platforms over time.
  • Edwards Lifesciences: Edwards provides hemodynamic monitoring used alongside anesthesia delivery in the OR and has explored closed-loop fluid and drug administration concepts, making it an adjacent incumbent with overlapping clinical use cases.
  • Koninklijke Philips: Philips provides perioperative patient monitoring and integrated OR solutions overlapping with Medsteer's clinical environment, and has been investing in decision-support and AI-driven anesthesia analytics that could converge with closed-loop dosing.
  • Becton Dickinson: BD offers infusion and medication management technologies used in surgical and ICU sedation settings, and competes in adjacent closed-loop and smart-pump categories relevant to Medsteer's dosing automation value proposition.

Direct peers

  • Masimo: Masimo's SedLine EEG-based depth-of-anesthesia monitor competes directly with the Medtronic/GE monitors that EasyTIVA relies on, and Masimo increasingly integrates analytics into its own OR platform, making it the closest adjacent competitor in EEG-guided anesthesia.
  • ICU Medical: ICU Medical (Smiths Medical infusion portfolio) supplies syringe pumps and infusion systems that are central to closed-loop drug delivery architectures like EasyTIVA, and is a direct adjacency in the closed-loop anesthesia technology stack.

Emerging players

  • Mindray: Mindray provides patient monitoring and anesthesia delivery systems including EEG-based depth-of-anesthesia modules, and is rapidly expanding in emerging markets, representing a growing lower-cost competitor to EasyTIVA's positioning.
  • Sedana Medical: Sedana Medical focuses on inhaled sedation in the ICU setting, an adjacent clinical use case to Medsteer's closed-loop IV anesthesia and sedation platform, with overlapping anesthesiology and critical care customer segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Medsteer social profiles

Digital presence

Medsteer financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medsteer leadership team

Management profile

Number of profiles

Profiles3 records

Medsteer funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medsteer M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medsteer

What does Medsteer do?

Medsteer sells the patented EasyTIVA technology platform, a closed-loop Total Intravenous Anesthesia (TIVA) system that fully automates the induction and regulation of Propofol and Remifentanil dosing during surgery. The platform uses a proprietary EEG-guided algorithm that ingests real-time depth-of-anesthesia index values (0–100) from compatible brain monitors and non-invasive forehead sensors, then drives standard syringe pumps in a closed-loop architecture to deliver precise drug amounts. The technology is targeted at hospitals, surgical centers, and anesthesiologists, and is also being licensed for integration into pharmaceutical platforms (e.g., Cyclerion's CYC-126).

Is Medsteer a public or private company?

Medsteer is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Medsteer founded?

Medsteer was founded in 2006. It employs 1 to 10 people.

Where is Medsteer based?

Medsteer is headquartered in Suresnes, France, in the Europe region.

Who are Medsteer's main competitors?

Broad incumbents on record are GE HealthCare, Medtronic, Drägerwerk, Edwards Lifesciences, Koninklijke Philips and Becton Dickinson. Direct peers are Masimo and ICU Medical. Emerging players are Mindray and Sedana Medical.

Does Medsteer have an API?

No public API is recorded for Medsteer.

What industry is Medsteer in?

Medsteer's product category is Closed-Loop Anesthesia Delivery Systems. Its primary akta.pro industry code is HLAHADAJ, Anesthesia & Airway Management Equipment (Workstations, Laryngoscopy, Ventilation adjuncts), with a secondary code of HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring. Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Psychiatric TimesPhase 2 Study of CYC-126 for Treatment Resistant Depression Receives FDA Feedback, Will ProceedCyclerion Therapeutics received constructive feedback from the US Food and Drug Administration on the Phase 2 study design for CYC-126, an anesthetic-based therapy with real-time EEG feedback for treatment-resistant depression, clarifying the drug's regulatory jurisdiction and development pathway. The Phase 2 trial will be a randomized, double-blind study using FDA-accepted endpoints including the Montgomery-Asberg Depression Rating Scale, with enrollment planned in Australia in H2 2026 and US enrollment in early 2027. The company has also partnered with Medsteer for software integration and formed a clinical advisory board to support clinical development.Investing.comCyclerion receives FDA feedback on depression treatment development By Investing.comCyclerion Therapeutics received positive written feedback from the FDA regarding its planned Phase 2 proof-of-concept study for CYC-126 in treatment-resistant depression, providing clarity on the regulatory pathway and study design. The company announced plans to initiate the Phase 2 study in the second half of 2026, with initial patient enrollment in Australia followed by U.S. enrollment in early 2027, and also disclosed a strategic exclusive collaboration with Medsteer to integrate EEG-guided technology into its closed-loop anesthetic platform.Investing.comCyclerion receives FDA feedback on depression treatment development By Investing.comCyclerion Therapeutics received positive written feedback from the FDA regarding its planned Phase 2 proof-of-concept study for CYC-126, an investigational anesthetic-based therapy for treatment-resistant depression, providing regulatory clarity on the study design. The company announced it will initiate the Phase 2 trial in the second half of 2026 with initial patient enrollment in Australia, followed by U.S. enrollment in the first half of 2027. Cyclerion also disclosed a strategic collaboration with Medsteer to integrate proprietary EEG-guided technology into its closed-loop anesthetic platform for CYC-126.Investing.comCyclerion Therapeutics stock soars after strategic Medsteer collaboration By Investing.comCyclerion Therapeutics stock surged 44.2% in after-hours trading following the announcement of a strategic collaboration with Medsteer to advance its closed-loop anesthetic platform for treatment-resistant depression. The collaboration grants Cyclerion access to Medsteer's EEG-guided closed-loop control technology, including computational modules, control software, and datasets developed across over 25 clinical settings and 9,000 patients. The company plans to initiate a Phase 2 proof-of-concept study in the second half of 2026, with first patient enrollment targeted in Australia and initial clinical data expected in 2027.GlobeNewswireCyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant DepressionCyclerion Therapeutics announced an option-to-license agreement with Medsteer to integrate closed-loop anesthetic delivery technology into its CYC-126 program for treatment-resistant depression. The company plans to initiate a Phase 2 proof-of-concept study in the second half of 2026, with initial data expected in 2027.